Dear Colleagues,

Gynecological cancers, including primary peritoneal cancer, tubo-ovarian cancer, uterine cancer, cervical cancer, vaginal cancer and vulvar cancer, remain a significant global health problem. Recent developments in surgery have contributed to the advancement of various surgical disciplines in the modern era, especially for gynecological cancers. One of these modern techniques is minimally invasive surgery, which reduces surgical intervention-related invasiveness but at the same time does not compromise therapeutic outcomes. Although surgery can be a primary treatment for most early-stage gynecological cancers, surgery might not be suitable for some patients. Moreover, patients with very advanced or recurrent disease often need multi-modality treatment or systemic therapy, as evidenced by the worse outcome of women treated by single modality therapy only. Fortunately, there is now considerable evidence showing significant therapeutic benefits from various kinds of adjuvant treatment, such as hormonal therapy, chemotherapy, targeted therapy, immunotherapy, and others. With these treatments, some patients may experience prolonged progression-free and overall survival.
This special issue welcomes investigators and clinical physicians worldwide to contribute original research articles and review articles that advance our knowledge of the management of gynecological cancers, based upon recent developments and the most updated techniques in this field.

Chia-Hao Liu and Peng-Hui Wang

Guest Editors